AR028667A1 - Derivados de higromicina a - Google Patents

Derivados de higromicina a

Info

Publication number
AR028667A1
AR028667A1 ARP010102642A ARP010102642A AR028667A1 AR 028667 A1 AR028667 A1 AR 028667A1 AR P010102642 A ARP010102642 A AR P010102642A AR P010102642 A ARP010102642 A AR P010102642A AR 028667 A1 AR028667 A1 AR 028667A1
Authority
AR
Argentina
Prior art keywords
compounds
formula
infections
protozoal infections
hygromycin
Prior art date
Application number
ARP010102642A
Other languages
English (en)
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of AR028667A1 publication Critical patent/AR028667A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D407/00Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/12Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D407/00Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/14Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D453/00Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/02Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/08Bridged systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20Carbocyclic rings
    • C07H15/203Monocyclic carbocyclic rings other than cyclohexane rings; Bicyclic carbocyclic ring systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Compuestos de formula 1 y sus sales, profármacos y solvatos farmacéuticamente aceptables de los mismos, en la que R1, R2, R3 y R10 son como se han definido en la memoria descriptiva. Los compuestos de formula 1 son agentes antibacterianos y antiprotozoarios que pueden usarse para tratar diversas infecciones bacterianas y protozoarias y trastornos relacionados con tales infecciones. También se refiere a composiciones farmacéuticas que contienen los compuestos de formula 1 y a procedimientos de tratamiento de infecciones bacterianas y protozoarias mediante la administracion de los compuestos de formula 1.
ARP010102642A 2000-06-02 2001-06-01 Derivados de higromicina a AR028667A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US20902300P 2000-06-02 2000-06-02

Publications (1)

Publication Number Publication Date
AR028667A1 true AR028667A1 (es) 2003-05-21

Family

ID=22777009

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP010102642A AR028667A1 (es) 2000-06-02 2001-06-01 Derivados de higromicina a

Country Status (31)

Country Link
US (1) US6867230B2 (es)
EP (1) EP1287011A1 (es)
JP (1) JP2003535100A (es)
KR (1) KR20030010655A (es)
CN (1) CN1432019A (es)
AP (1) AP2002002669A0 (es)
AR (1) AR028667A1 (es)
AU (1) AU2001260528A1 (es)
BG (1) BG107265A (es)
BR (1) BR0111242A (es)
CA (1) CA2410643A1 (es)
CZ (1) CZ20023859A3 (es)
EA (1) EA200201167A1 (es)
EC (1) ECSP014093A (es)
EE (1) EE200200671A (es)
GT (1) GT200100099A (es)
HU (1) HUP0302263A2 (es)
IL (1) IL152984A0 (es)
IS (1) IS6618A (es)
MA (1) MA26909A1 (es)
MX (1) MXPA02011966A (es)
NO (1) NO20025704L (es)
OA (1) OA12277A (es)
PA (1) PA8518101A1 (es)
PE (1) PE20020334A1 (es)
PL (1) PL359179A1 (es)
SK (1) SK16612002A3 (es)
SV (1) SV2002000474A (es)
TN (1) TNSN01080A1 (es)
UY (1) UY26741A1 (es)
WO (1) WO2001092280A1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2486055C (en) * 2002-05-16 2012-03-06 Sepracor, Inc. Amines that inhibit a mammalian anandamide transporter, and methods of use thereof
US20210275559A1 (en) * 2018-08-20 2021-09-09 Kim Lewis Hygromycin a compounds and methods of treating spirochete diseases
CU20180159A7 (es) * 2018-12-28 2020-10-20 Chengdu Olisynn Biotechnology Co Ltd Derivados de oligosacáridos sintéticos como vacuna contra la bordetella pertussis

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1234567A (en) * 1915-09-14 1917-07-24 Edward J Quigley Soft collar.
US2004123A (en) * 1934-02-15 1935-06-11 Jr Robert B Loibl Pest exterminator
CA2331261C (en) * 1998-05-04 2004-07-27 Pfizer Products Inc. 2"-deoxy hygromycin derivatives
IL139165A0 (en) * 1998-05-04 2001-11-25 Pfizer Prod Inc Hygromycin a derivatives
CA2352332C (en) * 1998-12-02 2004-12-07 Pfizer Products Inc. Hygromycin a derivatives
KR20020063885A (ko) * 1999-10-29 2002-08-05 화이자 프로덕츠 인코포레이티드 하이그로마이신 유도체
US7654321B2 (en) * 2006-12-27 2010-02-02 Schlumberger Technology Corporation Formation fluid sampling apparatus and methods

Also Published As

Publication number Publication date
NO20025704D0 (no) 2002-11-27
BR0111242A (pt) 2003-06-03
SK16612002A3 (sk) 2004-04-06
EA200201167A1 (ru) 2003-06-26
CZ20023859A3 (cs) 2004-02-18
GT200100099A (es) 2002-01-31
PE20020334A1 (es) 2002-04-30
OA12277A (en) 2006-05-11
HUP0302263A2 (hu) 2003-10-28
SV2002000474A (es) 2002-07-03
BG107265A (bg) 2003-07-31
IL152984A0 (en) 2003-06-24
US6867230B2 (en) 2005-03-15
CN1432019A (zh) 2003-07-23
NO20025704L (no) 2002-11-27
PA8518101A1 (es) 2002-09-17
AP2002002669A0 (en) 2002-12-31
UY26741A1 (es) 2001-12-28
PL359179A1 (en) 2004-08-23
CA2410643A1 (en) 2001-12-06
EE200200671A (et) 2004-08-16
KR20030010655A (ko) 2003-02-05
US20030045528A1 (en) 2003-03-06
AU2001260528A1 (en) 2001-12-11
EP1287011A1 (en) 2003-03-05
TNSN01080A1 (fr) 2005-11-10
IS6618A (is) 2002-11-14
WO2001092280A1 (en) 2001-12-06
ECSP014093A (es) 2002-01-25
JP2003535100A (ja) 2003-11-25
MA26909A1 (fr) 2004-12-20
MXPA02011966A (es) 2003-04-22

Similar Documents

Publication Publication Date Title
UY25780A1 (es) Nuevos antibióticos macrólidos
PA8489501A1 (es) Antibioticos cetolidos
AR019496A1 (es) Azalidas de 13 miembros, composiciones farmaceuticas, uso en la preparacion de medicamentos y preparacion de los mismos
DE60102171D1 (de) Ketolidantibiotika
PA8471801A1 (es) Derivados de higromicina a
AR028667A1 (es) Derivados de higromicina a
PT1167376E (pt) Antibioticos macrolidos
CR6503A (es) Derivados de- 1-trifluorometil-4-hidroxi-7-piperidinil-aminometiclcromano
AR019784A1 (es) Derivados de higromicina
PA8471901A1 (es) Derivados de 2"-desoxi higromicina
AR021816A1 (es) Antibioticos de carbamato y carbazato cetolida.
ECSP992943A (es) Derivados de higromicina a
ECSP992931A (es) Derivados de 2'' desoxi higromicina
AR026285A1 (es) Profarmacos de higromicina a
ECSP993239A (es) Derivados de higromicina
UY26418A1 (es) Profarmacos de higromicina a
ECSP003309A (es) Antibioticos cetolidos
UY26421A1 (es) Derivados de higromicina
PA8505601A1 (es) Profarmacos de higromicina a
ECSP993164A (es) Nuevos antibioticos macrolidos
ECSP992984A (es) Derivados de isotiazol utiles como agentes anticancerosos
ECSP993117A (es) Derivados de quinolin -2 - ona utiles como agentes contra el cancer
ECSP982755A (es) Compuestos azapoliciclicos condensados con arilo

Legal Events

Date Code Title Description
FB Suspension of granting procedure